• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Definium Therapeutics, Inc. - Common Shares (NQ:DFTX)

    45.56 +1.09 (+2.44%)
    Streaming Delayed Price Updated: 10:26 AM EDT, Jul 8, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 366,088
    Open 44.87
    Bid (Size) 45.43 (100)
    Ask (Size) 45.70 (200)
    Prev. Close 44.48
    Today's Range 44.87 - 46.81
    52wk Range 14.62 - 49.20
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Definium Therapeutics Announces New Employee Inducement Grants
    From Definium Therapeutics, Inc.
    Via Business Wire
    News headline image
    Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity
    EQNX::TICKER_START (NASDAQ:HELP),(NASDAQ:DFTX),(NASDAQ:CMPS),(NASDAQ:GHRS),(NYSE:JNJ) EQNX::TICKER_END 
    Via FinancialNewsMedia

    Performance

    YTD
    +196.3%
    +196.3%
    1 Month
    +97.9%
    +97.9%
    3 Month
    +121.4%
    +121.4%
    6 Month
    +196.3%
    +196.3%
    1 Year
    +196.3%
    +196.3%

    More News

    Read More
    News headline image
    Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity
    From MarketNewsUpdates.com
    Via GlobeNewswire
    Definium Therapeutics (NASDAQ:DFTX) Misses EPS but Pipeline Progress Steals the Spotlight ↗
    Via Chartmill
    News headline image
    Definium Therapeutics, Inc. Announces Closing of $805 Million Upsized Public Offering, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
    From Definium Therapeutics, Inc.
    Via Business Wire
    News headline image
    Definium Therapeutics, Inc. Announces Pricing of $700 Million Upsized Public Offering
    From Definium Therapeutics, Inc.
    Via Business Wire
    News headline image
    Definium Therapeutics, Inc. Announces Proposed Public Offering
    From Definium Therapeutics, Inc.
    Via Business Wire
    Top movers analysis one hour before the close of the markets on 2026-06-22: top gainers and losers in today's session. ↗
    Via Chartmill
    Which stocks are moving on Monday? ↗
    Via Chartmill
    Monday's session: gap up and gap down stocks ↗
    Via Chartmill
    News headline image
    Definium Therapeutics Announces Positive Topline Results from Phase 3 Emerge Study of DT120 Orally Disintegrating Tablet (ODT) in Major Depressive Disorder
    From Definium Therapeutics, Inc.
    Via Business Wire
    News headline image
    Definium Therapeutics to Discuss Topline Results from Phase 3 Emerge Study in Major Depressive Disorder on June 22, 2026
    From Definium Therapeutics, Inc.
    Via Business Wire
    News headline image
    Definium Therapeutics Announces New Employee Inducement Grants
    From Definium Therapeutics, Inc.
    Via Business Wire
    News headline image
    Definium Therapeutics Announces New Employee Inducement Grants
    From Definium Therapeutics, Inc.
    Via Business Wire
    News headline image
    Definium Therapeutics Eyes Key DT-120 Depression Data, Advances Anxiety Program ↗
    Via MarketBeat
    News headline image
    Definium Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
    From Definium Therapeutics, Inc.
    Via Business Wire
    News headline image
    What to Know About This Fund’s New $22 Million Xenon Pharmaceuticals Buy Ahead of an FDA Filing ↗
    Via The Motley Fool
    News headline image
    Dianthus Therapeutics Is Up 320% in a Year. One Major Investor Just Reduced Its Stake but Still Seems Bullish ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Definium Therapeutics Announces First Patient Dosed in Ascend, the Second Phase 3 Pivotal Study of DT120 ODT in Major Depressive Disorder
    From Definium Therapeutics, Inc.
    Via Business Wire
    News headline image
    Definium Therapeutics Announces New Employee Inducement Grants
    From Definium Therapeutics, Inc.
    Via Business Wire
    News headline image
    Definium (DFTX) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Definium Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights
    From Definium Therapeutics, Inc.
    Via Business Wire
    News headline image
    Definium Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026
    From Definium Therapeutics, Inc.
    Via Business Wire
    News headline image
    These 3 Psychedelic Stocks Activated After Trump's Executive Order ↗
    Via MarketBeat
    Topics Government
    News headline image
    Definium Therapeutics Highlights DT120 ODT (Lysergide Tartrate) Clinical Advancements and Commercial Strategy at Investor and Analyst Day
    From Definium Therapeutics, Inc.
    Via Business Wire

    Frequently Asked Questions

    Is Definium Therapeutics, Inc. - Common Shares publicly traded?
    Yes, Definium Therapeutics, Inc. - Common Shares is publicly traded.
    What exchange does Definium Therapeutics, Inc. - Common Shares trade on?
    Definium Therapeutics, Inc. - Common Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Definium Therapeutics, Inc. - Common Shares?
    The ticker symbol for Definium Therapeutics, Inc. - Common Shares is DFTX on the Nasdaq Stock Market
    What is the current price of Definium Therapeutics, Inc. - Common Shares?
    The current price of Definium Therapeutics, Inc. - Common Shares is 45.56
    When was Definium Therapeutics, Inc. - Common Shares last traded?
    The last trade of Definium Therapeutics, Inc. - Common Shares was at 07/08/26 10:26 AM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.